Drug Information

Drug General Information
Drug ID
D09ZMV
Former ID
DIB010998
Drug Name
Votucalis ophthalmic
Synonyms
EV-131; REV-131; Tick-derived compounds, Evolutec; Votucalis (intranasal), Evolutec; Votucalis (ophthalmic), Evolutec; Votucalis (respiratory disease), Evolutec; REV-131 (intranasal), Evolutec; REV-131 (ophthalmic), Evolutec; REV-131 (respiratory disease), Evolutec
Indication Allergic rhinitis [ICD9: 472.0, 477, 995.3; ICD10:J00, J30, J31.0, T78.4] Phase 2 [521858]
Company
Evolutec Group plc; Evolutec
CAS Number
CAS 872525-61-6
Target and Pathway
Target(s) Histamine receptor Target Info Antagonist [550831]
References
Ref 521858ClinicalTrials.gov (NCT00353964) Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery. U.S. National Institutes of Health.
Ref 550831CA patent application no. 520580, Histamine binding compounds for treatment method for disease conditions mediated by neutrophils.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.